Parkside Financial Bank & Trust’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.6K Buy
260
+91
+54% +$3.85K ﹤0.01% 1639
2025
Q4
$7.83K Hold
169
﹤0.01% 1662
2025
Q3
$5.91K Buy
169
+15
+10% +$521 ﹤0.01% 1694
2025
Q2
$4.55K Buy
154
+26
+20% +$742 ﹤0.01% 1731
2025
Q1
$3.82K Buy
128
+15
+13% +$458 ﹤0.01% 1712
2024
Q4
$3.24K Hold
113
﹤0.01% 1540
2024
Q3
$4.37K Buy
113
+12
+12% +$428 ﹤0.01% 1461
2024
Q2
$3.25K Buy
101
+24
+31% +$832 ﹤0.01% 1463
2024
Q1
$2.99K Buy
77
+71
+1,183% +$2.48K ﹤0.01% 1445
2023
Q4
$185 Sell
6
-47
-89% -$1.18K ﹤0.01% 1955
2023
Q3
$1.19K Sell
53
-47
-47% -$1.07K ﹤0.01% 1797
2023
Q2
$2.15K Hold
100
﹤0.01% 1667
2023
Q1
$2.4K Hold
100
﹤0.01% 1644
2022
Q4
$2.32K Hold
100
﹤0.01% 1629
2022
Q3
$2K Buy
100
+94
+1,567% +$1.66K ﹤0.01% 1515
2022
Q2
$0 Sell
6
-115
-95% -$1.94K ﹤0.01% 1833
2022
Q1
$2K Buy
+121
New +$2.29K ﹤0.01% 1581
2021
Q3
Sell
-72
Closed -$2K 1767
2021
Q2
$2K Buy
+72
New +$1.66K ﹤0.01% 1517

Other funds holding COLL

Parkside Financial Bank & Trust's COLL Position: Q1 2026 in Review

Parkside Financial Bank & Trust increased its Collegium Pharmaceutical (COLL) stake by 54% in Q1 2026, buying an estimated $3.85K and bringing the position to 260 shares worth $8.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1639.

Parkside Financial Bank & Trust first reported a position in COLL in Q2 2021 and has held it in 18 quarters since. 267 funds tracked by Wall St. Rank hold COLL as of Q1 2026.

  • Parkside Financial Bank & Trust held 260 shares of Collegium Pharmaceutical worth $8.6K as of Q1 2026.
  • Parkside Financial Bank & Trust bought 91 Collegium Pharmaceutical shares in Q1 2026, an estimated $3.85K.
  • Collegium Pharmaceutical made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #1639 holding.
  • Parkside Financial Bank & Trust first reported a position in Collegium Pharmaceutical in Q2 2021 and has held it in 18 quarters since.
  • 267 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.